| Lantheus Holdings, Inc | $6.5b | $100.98 | -0.4% | 2.1M | |
| Immunome, Inc. | $2.6b | $25.82 | +1.4% | 679.5K | |
| AbCellera Biologics Inc. Common Shares | $1.7b | $6.46 | +10.1% | 7.9M | |
| Aktis Oncology, Inc. Common stock | $1.2b | $23.43 | +3.7% | 235.8K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.1b | $13.12 | -1.8% | 357.6K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $16.41 | +4.4% | 116.8K | |
| Perspective Therapeutics, Inc. | $331.9m | $3.03 | +1.0% | 416.6K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| Actinium Pharmaceuticals, Inc | $26.3m | $0.78 | +5.1% | 98.0K | |
| American Shared Hospital Services | $9.9m | $1.46 | -2.0% | 10.5K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $4.6m | $0.29 | 0.0% | 25.7K |